[HTML][HTML] Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
Merkel cell carcinoma (MCC) is a rare tumour of the skin of neuro-endocrine origin probably
developing from neuronal mechanoreceptors. A collaborative group of multidisciplinary …
developing from neuronal mechanoreceptors. A collaborative group of multidisciplinary …
Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline–Update 2022
ML Gauci, C Aristei, JC Becker, A Blom… - European Journal of …, 2022 - Elsevier
Merkel cell carcinoma (MCC) is a rare skin cancer, accounting for less than 1% of all
cutaneous malignancies. It is found predominantly in white populations and risk factors …
cutaneous malignancies. It is found predominantly in white populations and risk factors …
Merkel cell carcinoma: critical review with guidelines for multidisciplinary management
CK Bichakjian, L Lowe, CD Lao, HM Sandler… - Cancer, 2007 - Wiley Online Library
Merkel cell carcinoma (MCC) is a relatively rare cutaneous malignancy that occurs
predominantly in the older white population. The incidence of MCC appears to have tripled …
predominantly in the older white population. The incidence of MCC appears to have tripled …
Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy
RE Warner, MJ Quinn, G Hruby, RA Scolyer… - Annals of Surgical …, 2008 - Springer
Background Merkel cell carcinoma (MCC) is an uncommon, highly aggressive skin
malignancy with a propensity to recur locally and regionally. However, its optimal treatment …
malignancy with a propensity to recur locally and regionally. However, its optimal treatment …
S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin)–update 2018
JC Becker, T Eigentler, B Frerich… - JDDG: Journal der …, 2019 - Wiley Online Library
Merkel cell carcinoma (MCC, ICD‐O M8247/3) is a rare malignant primary skin tumor with
epithelial and neuroendocrine differentiation. The neoplastic cells share many …
epithelial and neuroendocrine differentiation. The neoplastic cells share many …
Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases
H Medina-Franco, MM Urist, J Fiveash… - Annals of surgical …, 2001 - Springer
Background: Merkel cell carcinoma (MCC) is an unusual and potentially aggressive cancer
of the skin. There is no consensus regarding the optimal therapeutic approach, and the …
of the skin. There is no consensus regarding the optimal therapeutic approach, and the …
Merkel cell carcinoma review
Y Xue, M Thakuria - Hematology/Oncology Clinics, 2019 - hemonc.theclinics.com
Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous malignancy of
neuroendocrine origin. It was first described in 1972 by Toker, 1 who named it “trabecular …
neuroendocrine origin. It was first described in 1972 by Toker, 1 who named it “trabecular …
Merkel cell carcinoma
Merkel cell carcinoma (MCC) is a rare but highly aggressive skin cancer with
neuroendocrine features. MCC pathogenesis is associated with either the presence of …
neuroendocrine features. MCC pathogenesis is associated with either the presence of …
[HTML][HTML] Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy
A Servy, E Maubec, PE Sugier, F Grange, S Mansard… - Annals of …, 2016 - Elsevier
Background Sentinel lymph-node (LN) biopsy (SLNB) is a valuable tool to assess the
regional LN status in Merkel cell carcinoma (MCC). However, its prognostic value is still …
regional LN status in Merkel cell carcinoma (MCC). However, its prognostic value is still …
Merkel cell carcinoma: 30-year experience from a single institution
JA Santamaria-Barria, GM Boland, BY Yeap… - Annals of surgical …, 2013 - Springer
Background Merkel cell carcinoma (MCC) is a rare cutaneous malignancy. Few single-
institution series have been reported. Methods Review of MCC patients treated at our …
institution series have been reported. Methods Review of MCC patients treated at our …